CN1430621A - 制备乙烯基-吡咯烷酮头孢菌素衍生物的新方法 - Google Patents
制备乙烯基-吡咯烷酮头孢菌素衍生物的新方法 Download PDFInfo
- Publication number
- CN1430621A CN1430621A CN01809931A CN01809931A CN1430621A CN 1430621 A CN1430621 A CN 1430621A CN 01809931 A CN01809931 A CN 01809931A CN 01809931 A CN01809931 A CN 01809931A CN 1430621 A CN1430621 A CN 1430621A
- Authority
- CN
- China
- Prior art keywords
- formula
- group
- compound
- under
- protection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/57—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with a further substituent in position 7, e.g. cephamycines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
- C07F9/65613—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system (X = CH2, O, S, NH) optionally with an additional double bond and/or substituents, e.g. cephalosporins and analogs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/572—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/582—Recycling of unreacted starting or intermediate materials
Abstract
Description
Claims (18)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00111164.0 | 2000-05-24 | ||
EP00111164 | 2000-05-24 |
Related Child Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2006101392763A Division CN100567314C (zh) | 2000-05-24 | 2001-05-18 | 制备乙烯基-吡咯烷酮头孢菌素衍生物的新方法 |
CN2006101392778A Division CN1915997B (zh) | 2000-05-24 | 2001-05-18 | 制备乙烯基-吡咯烷酮头孢菌素衍生物的新方法 |
CNB2004100700310A Division CN1301998C (zh) | 2000-05-24 | 2001-05-18 | 制备乙烯基-吡咯烷酮头孢菌素衍生物的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1430621A true CN1430621A (zh) | 2003-07-16 |
CN1170831C CN1170831C (zh) | 2004-10-13 |
Family
ID=8168825
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2006101392763A Expired - Lifetime CN100567314C (zh) | 2000-05-24 | 2001-05-18 | 制备乙烯基-吡咯烷酮头孢菌素衍生物的新方法 |
CN2006101392778A Expired - Lifetime CN1915997B (zh) | 2000-05-24 | 2001-05-18 | 制备乙烯基-吡咯烷酮头孢菌素衍生物的新方法 |
CNB2004100700310A Expired - Lifetime CN1301998C (zh) | 2000-05-24 | 2001-05-18 | 制备乙烯基-吡咯烷酮头孢菌素衍生物的方法 |
CNB018099319A Expired - Lifetime CN1170831C (zh) | 2000-05-24 | 2001-05-18 | 制备乙烯基-吡咯烷酮头孢菌素衍生物的新方法 |
Family Applications Before (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2006101392763A Expired - Lifetime CN100567314C (zh) | 2000-05-24 | 2001-05-18 | 制备乙烯基-吡咯烷酮头孢菌素衍生物的新方法 |
CN2006101392778A Expired - Lifetime CN1915997B (zh) | 2000-05-24 | 2001-05-18 | 制备乙烯基-吡咯烷酮头孢菌素衍生物的新方法 |
CNB2004100700310A Expired - Lifetime CN1301998C (zh) | 2000-05-24 | 2001-05-18 | 制备乙烯基-吡咯烷酮头孢菌素衍生物的方法 |
Country Status (16)
Country | Link |
---|---|
US (1) | US6504025B2 (zh) |
EP (2) | EP1435357B1 (zh) |
JP (1) | JP3994011B2 (zh) |
KR (1) | KR100528305B1 (zh) |
CN (4) | CN100567314C (zh) |
AT (2) | ATE461203T1 (zh) |
AU (1) | AU2001262299A1 (zh) |
CA (2) | CA2408941C (zh) |
CY (1) | CY1110298T1 (zh) |
DE (2) | DE60141609D1 (zh) |
DK (2) | DK1435357T3 (zh) |
ES (2) | ES2340273T3 (zh) |
HK (3) | HK1074620A1 (zh) |
MX (1) | MXPA02011530A (zh) |
PT (2) | PT1289998E (zh) |
WO (1) | WO2001090111A1 (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103275104A (zh) * | 2013-05-15 | 2013-09-04 | 苏州明锐医药科技有限公司 | 头孢托罗及头孢托罗酯的制备方法 |
CN104892635A (zh) * | 2010-05-10 | 2015-09-09 | 巴斯利尔药物国际有限公司 | 制备3-甲酰基-头孢霉毒核衍生物的氧化方法 |
CN105601648A (zh) * | 2016-03-09 | 2016-05-25 | 上海宁瑞生化技术有限公司 | 一锅法制备头孢吡普的方法 |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1302456B1 (de) | 2001-10-11 | 2004-01-02 | Consortium für elektrochemische Industrie GmbH | Verfahren zur Oxidation von Alkoholen unter Katalyse von Nitroxylverbindungen |
ES2329244T3 (es) * | 2003-03-27 | 2009-11-24 | Basilea Pharmaceutica Ag | Cefalosporina en forma cristalina. |
EA201070504A1 (ru) * | 2007-10-25 | 2010-12-30 | Эйкеоджен, Инк. | КАРБАЦЕФЕМ β-ЛАКТАМОВЫЕ АНТИБИОТИКИ |
AR071318A1 (es) * | 2008-04-15 | 2010-06-09 | Basilea Pharmaceutica Ag | Benzhidril ester del acido (6r,7r)-7-{2-(5-amino-[1,2,4]tiadiazol-3-il)-2-[(z)-tritiloxiimino]-acetilamino}-3-[(r)-1'-terc-butoxicarbonil-2-oxo-[1,3']bipirrolidinil-(3e)-ilidenometil]-8-oxo-5-tia-1-aza-biciclo[4.2.0]oct-2-eno-2-carboxilico cristalino; su elaboracion y uso |
WO2010030810A1 (en) * | 2008-09-10 | 2010-03-18 | Achaogen, Inc. | Carbacephem beta-lactam antibiotics |
WO2010072672A1 (en) | 2008-12-24 | 2010-07-01 | Basilea Pharmaceutica Ag | New crystal polymorphs of ceftobiprole |
EP2435442B1 (de) * | 2009-05-25 | 2016-01-13 | Sandoz AG | Verfahren zur herstellung von ceftobiprol medocaril |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0620225B1 (en) * | 1993-04-16 | 2002-11-13 | Basilea Pharmaceutica AG | Cephalosporin derivatives |
US5466811A (en) | 1994-07-18 | 1995-11-14 | Merck & Co., Inc. | Dioxolenylmethyl carbamates pro moieties for amine drugs |
US5631366A (en) * | 1995-01-12 | 1997-05-20 | Hoffmann-La Roche Inc. | Process for making 3-formylcephem derivatives |
KR100197788B1 (ko) | 1995-06-30 | 1999-06-15 | 김충환 | 세펨 유도체의 제조방법 |
US5883247A (en) | 1996-06-10 | 1999-03-16 | Hoffmann-La Roche Inc. | Preparation of cephem and isooxacephem derivatives |
TW415949B (en) | 1996-12-19 | 2000-12-21 | Hoffmann La Roche | Vinyl pyrrolidine cephalosporin derivatives with basic substituents |
PL200130B1 (pl) * | 1997-04-01 | 2008-12-31 | Nabriva Therapeutics Forschung | Podstawione pochodne 7-acyloamino-3-(metylohydrazono)metylocefalosporyny, sposób ich wytwarzania, kompozycja farmaceutyczna zawierająca takie pochodne, zastosowania tych pochodnych oraz związki pośrednie służące do otrzymywania podstawionych 7-acyloamino-3-(metylohydrazono)metylocefalosporyn |
BRPI9911178B8 (pt) | 1998-06-15 | 2017-03-07 | Basilea Pharmaceutica Ag | derivados de 3-(2-oxo-[1,3']bipirrolidinil-3-ilidenometil)-cefems, bem como preparação farmacêutica e uso dos mesmos |
-
2001
- 2001-05-17 US US09/860,157 patent/US6504025B2/en not_active Expired - Lifetime
- 2001-05-18 KR KR10-2002-7015823A patent/KR100528305B1/ko active IP Right Grant
- 2001-05-18 DE DE60141609T patent/DE60141609D1/de not_active Expired - Lifetime
- 2001-05-18 DK DK04002120.6T patent/DK1435357T3/da active
- 2001-05-18 CN CNB2006101392763A patent/CN100567314C/zh not_active Expired - Lifetime
- 2001-05-18 DE DE60109771T patent/DE60109771T2/de not_active Expired - Lifetime
- 2001-05-18 JP JP2001586298A patent/JP3994011B2/ja not_active Expired - Lifetime
- 2001-05-18 AT AT04002120T patent/ATE461203T1/de active
- 2001-05-18 MX MXPA02011530A patent/MXPA02011530A/es active IP Right Grant
- 2001-05-18 DK DK01936374T patent/DK1289998T3/da active
- 2001-05-18 CA CA002408941A patent/CA2408941C/en not_active Expired - Lifetime
- 2001-05-18 CN CN2006101392778A patent/CN1915997B/zh not_active Expired - Lifetime
- 2001-05-18 CN CNB2004100700310A patent/CN1301998C/zh not_active Expired - Lifetime
- 2001-05-18 AU AU2001262299A patent/AU2001262299A1/en not_active Abandoned
- 2001-05-18 CA CA2583727A patent/CA2583727C/en not_active Expired - Lifetime
- 2001-05-18 CN CNB018099319A patent/CN1170831C/zh not_active Expired - Lifetime
- 2001-05-18 EP EP04002120A patent/EP1435357B1/en not_active Expired - Lifetime
- 2001-05-18 EP EP01936374A patent/EP1289998B1/en not_active Expired - Lifetime
- 2001-05-18 WO PCT/EP2001/005721 patent/WO2001090111A1/en active Search and Examination
- 2001-05-18 PT PT01936374T patent/PT1289998E/pt unknown
- 2001-05-18 ES ES04002120T patent/ES2340273T3/es not_active Expired - Lifetime
- 2001-05-18 PT PT04002120T patent/PT1435357E/pt unknown
- 2001-05-18 ES ES01936374T patent/ES2238441T3/es not_active Expired - Lifetime
- 2001-05-18 AT AT01936374T patent/ATE292135T1/de active
-
2005
- 2005-08-09 HK HK05106830A patent/HK1074620A1/xx unknown
-
2007
- 2007-03-26 HK HK07103185.2A patent/HK1096101A1/xx not_active IP Right Cessation
- 2007-03-26 HK HK07103186.1A patent/HK1096091A1/xx unknown
-
2010
- 2010-05-28 CY CY20101100471T patent/CY1110298T1/el unknown
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104892635A (zh) * | 2010-05-10 | 2015-09-09 | 巴斯利尔药物国际有限公司 | 制备3-甲酰基-头孢霉毒核衍生物的氧化方法 |
CN104892635B (zh) * | 2010-05-10 | 2017-12-05 | 巴斯利尔药物国际有限公司 | 制备3‑甲酰基‑头孢霉毒核衍生物的氧化方法 |
CN103275104A (zh) * | 2013-05-15 | 2013-09-04 | 苏州明锐医药科技有限公司 | 头孢托罗及头孢托罗酯的制备方法 |
CN105601648A (zh) * | 2016-03-09 | 2016-05-25 | 上海宁瑞生化技术有限公司 | 一锅法制备头孢吡普的方法 |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102033802B1 (ko) | 항-바이러스 뉴클레오티드 유사체의 제조 방법 | |
CN1170831C (zh) | 制备乙烯基-吡咯烷酮头孢菌素衍生物的新方法 | |
CN101056672A (zh) | 制备{3-[2(r)-[(1r)-1-[3,5-二(三氟甲基)苯基]乙氧基]-3(s)-(4-氟苯基)吗啉-4-基 ]甲基]-5-氧代-4,5-二氢-[1,2,4]-三唑-1-基}膦酸的方法 | |
CN1092662C (zh) | 头孢菌素合成 | |
CN1458932A (zh) | 作为抗菌剂的3-(杂芳基乙酰氨基)-2-氧代-氮杂环丁烷-1-磺酸衍生物 | |
CN1126989A (zh) | 合成氮杂环丁酮类化合物的方法 | |
CN1037709A (zh) | 从3-三氟甲磺酰基头孢烯制备3-不饱和烃基头孢烯 | |
CN1150950A (zh) | 头孢菌素衍生物 | |
CN1279033C (zh) | 水溶性唑化合物的改善方法 | |
HU187685B (en) | Process for preparing 2-oxo-1-/substituted phosphinyl/-azetidines | |
CN1015714B (zh) | 制备7-氨基-3-丙烯基头孢菌素酸及其脂类的方法 | |
CN1247562C (zh) | 制备螺环季酮酸衍生物的方法 | |
CN1252788A (zh) | 制备药用化合物的方法 | |
CN1176641A (zh) | 3-吡咯烷亚基-2-酮-头孢菌素衍生物 | |
CN1147498C (zh) | 制备氧氮杂膦-2-胺的方法 | |
CN1915998A (zh) | β-内酰胺中间体结晶 | |
CN1237178A (zh) | 新型β-内酰胺化合物及其制备方法 | |
CN1243126A (zh) | 制备手性内酯的方法 | |
CN1930173A (zh) | 使用α-碘代-1-氮杂环丁烷乙酸酯和三烷基亚磷酸盐制备头孢菌素中间体的方法 | |
CN1240710C (zh) | 制备双环化合物的方法以及该方法在制备ice抑制剂化合物中的用途 | |
CN1097424A (zh) | β-内酰胺化合物及其有关中间体的制备 | |
JPWO2018003945A1 (ja) | 二環式化合物の製造方法 | |
JP2006096679A (ja) | セファロスポリン化合物の製造方法 | |
KR20070102254A (ko) | 카바페넴 중간체의 제조방법 | |
CN1081668A (zh) | (1′r,3s,4r)4-酰硫基氮杂环丁酮 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20181012 Address after: Basel Patentee after: Basilea Pharmaceutica International Ltd. Address before: Swiss Bin Ninggen Patentee before: Baslier Pharmaceutical AG |
|
EE01 | Entry into force of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20030716 Assignee: SHENZHEN CHINA RESOURCES GOSUN PHARMACEUTICAL CO., LTD. Assignor: Basilea Pharmaceutica International Ltd. Contract record no.: 2019990000040 Denomination of invention: New process for the preparation of vinyl-pyrrolidinone cephalosporine derivatives Granted publication date: 20041013 License type: Exclusive License Record date: 20190201 |
|
CX01 | Expiry of patent term | ||
CX01 | Expiry of patent term |
Granted publication date: 20041013 |